Non-syndromic arthrogryposis multiplex congenita (AMC) is characterized by multiple congenital contractures resulting from reduced fetal mobility. Genetic mapping and whole exome sequencing (WES) were performed in 31 multiplex and/or consanguineous undiagnosed AMC families. Although this approach identified known AMC genes, we here report pathogenic mutations in two new genes. Homozygous frameshift mutations in CNTNAP1 were found in four unrelated families. Patients showed a marked reduction in motor nerve conduction velocity (<10 m/s) and transmission electron microscopy (TEM) of sciatic nerve in the index cases revealed severe abnormalities of both nodes of Ranvier width and myelinated axons. CNTNAP1 encodes CASPR, an essential component of node of Ranvier domains which underlies saltatory conduction of action potentials along the myelinated axons, an important process for neuronal function. A homozygous missense mutation in adenylate cyclase 6 gene (ADCY6) was found in another family characterized by a lack of myelin in the peripheral nervous system (PNS) as determined by TEM. Morpholino knockdown of the zebrafish orthologs led to severe and specific defects in peripheral myelin in spite of the presence of Schwann cells. ADCY6 encodes a protein that belongs to the adenylate cyclase family responsible for the synthesis of cAMP. Elevation of cAMP can mimic axonal contact in vitro and upregulates myelinating signals. Our data indicate an essential and so far unknown role of ADCY6 in PNS myelination likely through the cAMP pathway. Mutations of genes encoding proteins of Ranvier domains or involved in myelination of Schwann cells are responsible for novel and severe human axoglial diseases.
INTRODUCTION
Arthrogryposis multiplex congenita (AMC) is characterized by congenital contractures of at least two distinct joints of the body. The overall incidence is 1 in 3000 of live births (1, 2) . Some non-genetic factors may cause AMC, such as mechanical limitation of fetal movements or maternal autoimmune myasthenia. A number of genetic syndromes including AMC phenotype, collectively referred to as syndromic AMC, have been described under several conditions (3, 4) . Non-syndromic or isolated AMCs are the direct consequence of fetal akinesia/hypokinesia sequence which may lead, in addition to AMCs, to pterygia, lung hypoplasia, diaphragmatic defect or cleft palate. 
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The difficulty in establishing a genetic diagnosis for AMC patients is likely due to the high genetic heterogeneity and/or to some not yet identified disease-causing genes. Moreover, there is a lack of suitable screening methods of all known AMC genes. In order to gain further insight into the underlying cause of these diseases, we took advantage of the added value of whole genome scanning using SNP microarrays alone or combined with whole exome sequencing (WES) to study a cohort of 31 multiplex and/or consanguineous families with undiagnosed non-syndromic AMC.
RESULTS

Phenotypic characterization of AMC patients
We enrolled 63 affected fetuses, children or adults belonging to 31 multiplex and/or consanguineous families with unexplained non-syndromic AMC (Supplementary Material, Fig. S1 ). The main clinical criteria were the gestational stage of AMC diagnosis based on the ultrasound examination (weeks' gestation, wg, the earliest one in multiplex families), the topography of joint contractures, associated symptoms including reduced fetal mobility, pterygium, micrognathia and cleft palate, the amount of amniotic fluid, and cystic hygroma ( Table 1 ). The stage of AMC diagnosis showed a marked heterogeneity of fetal onset starting from 11 wg and up to 32 wg. Reduced fetal mobility was associated with AMC in 24 out of 28 affected individuals (86%). No information was available in three families. Targeted  gene tests when performed did not lead to a diagnosis (Supplementary Material, Table S1 ). The primary defects were established based on gene identification and function (see below) and were classified as skeletal muscle, NMJ or axoglial AMC. AMCs associated with pterygia, both distal and proximal contractures or cystic hygroma, are significantly more frequent in skeletal muscle or NMJ than axoglial classes (P , 0.02, Fisher's exact test, Fig. 1 ).
Identification of mutations in genes known to be responsible for AMC or neuromuscular disorders
The overall strategy for gene identification is depicted in Supplementary Material, Figure S2 . Candidate loci were identified in each family by multipoint linkage analysis and homozygosity mapping by using SNP microarrays. When a single known AMC gene was identified in candidate disease loci, Sanger sequencing of exons and intron-exon junctions was performed. This was successfully applied in three families linked to mutations of RYR1 (family B415), TRPV4 (family B651, Table 2,  Supplementary Material, Table S2 and Supplementary Material, Fig. S3 ) or ECEL1 (family B192, 5). When numerous or none of the AMC genes were identified in candidate loci, WES was performed using the DNA sample of one affected individual per family (n ¼ 27). As a first filtering, homozygous or compound heterozygous variants mapping to the disease loci were selected in recessive and heterozygous variants in dominant forms, respectively (Table 2 and Supplementary Material, Table S2 ). Variants were then filtered against a list of genes known to be involved in AMC or neuromuscular disorders (NMDs). Mutations in NEB, RYR1, SYNE1, TNNT3, TTN or CHRNG genes were successfully identified in 10 out of 31 families (32%, Table 2 and Supplementary Material, Figs S3 and S4). Interestingly, homozygous stop gained mutation was found in exon 136 of SYNE-1 in family K168, which confirms that mutations of SYNE-1 are responsible for AMC since a single AMC family only was previously reported (6) . In family A642, a non-sense mutation on one allele and a frameshift mutation on the other allele of TTN were found extending the clinical spectrum of TTN gene mutations. In a consanguineous family (A659), a homozygous splice mutation was found in RBBP8 ( (Table 2 and Supplementary Material, Fig. S3 ). When no mutations were identified using these filters, the hypothesis of dominant de novo mutation was tested by selecting variants within AMC or NMD genes without any linkage data filter. A single missense mutation of the MYH3 gene was identified in the affected fetuses of family A640, the father showing somatic mosaicism pattern (Table 2 and Supplementary Material, Fig. S3 ).
Identification of mutations in CNTNAP1 encoding CASPR, an essential component of node of Ranvier domains
In two consanguineous families (K182, A641), homozygous frameshift mutations were found in CNTNAP1 encoding CASPR ( Fig. 2 and Table 2 ). In family A641, the three fetuses born from consanguineous parents carry a homozygous 1 bp deletion in CNTNAP1 exon 18 (c.2901_2902del), leading to frameshift and premature stop codon (P967PfsX12). In family K182, affected patients carry a homozygous 1 bp insertion in CNTNAP1 exon 19 (c.3009_3010insT) leading to frameshift (F1003fs). Two additional families with a similar phenotype (see below) were found to carry deleterious mutations in the same gene using either the combination of both linkage analysis with WES (family K199) or homozygosity mapping only (B207). In the consanguineous family K199, affected patients carry the same homozygous 1 bp insertion in CNTNAP1 exon 19 (c.3009_3010insT) as the unrelated family K182. In family B207, a homozygous frameshift mutation in exon 19 of CNTNAP1 was found in the patient (intron18-exon19:c.2993-2_2994del, I999WfsX5). In families K182 and A641, both parents were heterozygous for the mutation as expected. In families K199 and B207, DNA samples from parents were not available. These mutations were absent in 95 ethnically matched controls. The c.2901_2902del mutation was found at a very low minor allele frequency (MAF: 0.00016) in the current Exome Variant Server database (EVS, ESP6500SI-V2). The other mutations were found in neither EVS nor dbSNPv138.
In the four families, the fetal phenotype was quite similar (Table 3 ) and characterized by a late onset during pregnancy (from 28 wg), polyhydramnios and distal joint contractures, including talipes equinovarus and both proximal and distal interphalangeal joint contractures of the hands (Fig. 3) . Proximal joints were not involved. At birth, the patients displayed severe hypotonia, facial diplegia and a lack of swallowing, autonomous respiratory function and deep tendon reflexes (Fig. 3 ). Motor nerve conduction velocity was markedly reduced (,10 m/s). In all patients, death occurred within the first 2 months of life. Since CASPR is known to play a key role in the delineation of the axonal domains of myelinated axons in mice (9) , transmission electron microscopy (TEM) of sciatic nerve in the A641 and K182 index cases was performed and this revealed two major abnormalities (Fig. 4) . First, examination of longitudinal sections revealed a marked widening of the nodes of Ranvier in patient A641 (3.98 + 0.56; n ¼ 5) when compared with control (1.12 + 0.98; n ¼ 4, P , 0.05; Fig. 4 ). Second, in transverse sections, myelinated axons of K182 patient nerve (n ¼ 50) displayed a significant reduced surface associated with thinner myelin sheath when compared with an age-matched control case (n ¼ 69, Fig. 4 , P ¼ 0.04 and P , 0.0003, respectively, Kruskal-Wallis test). Similar abnormalities of myelinated axons were found in K199 and B207 patient's nerve (data not shown, available on request).
Identification of mutations in ADCY6 reveals an essential and so far unknown role of ADCY6 in myelination of Schwann cells
In the consanguineous family A649, a homozygous missense mutation predicted to be damaging using Polyphen-2 (10) with a high score (1.00) was found in ADCY6 (c.C3346T, 
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p. R1116C, Fig. 2 and Table 2 ). This mutation was found in neither EVS nor dbSNPv138. The phenotype of patients was similar to that carrying CNTNAP1 mutations (Table 3 ). Patient nerve immunohistochemistry using an S100 protein antibody revealed Schwann cells but all nerve fascicles were negative for MBP antibodies (Supplementary Material, Fig. S5 ). TEM of nerve revealed no myelinated axons (Fig. 4) . Some redundant basal lamina of Schwann cells were also observed, suggesting inability of Schwann cells to properly myelinate axons. Antisense morpholino oligonucleotides and their corresponding 'mismatch' controls were designed to specifically knockdown the ADCY6 orthologs in zebrafish (adcy6a and adcy6b, Supplementary Material, Table S3 ). Knockdown of the ADCY6 orthologs in zebrafish led to a very similar phenotype as observed in patients (Fig. 5 ) with a loss of mbp expression in the peripheral nervous system (PNS, showed here is the Posterior Lateral Line nerve, n ¼ 36/38) while the central nervous system mbp expression was comparable with controls. Furthermore, we also found no defects in Schwann cell migration and axonal growth in the morphants by using transgenic line foxd3::GFP (11) and acetylated tubulin antibody staining, respectively (Fig. 5) .
DISCUSSION
To our knowledge, this is the first study of a large cohort of undiagnosed AMC individuals investigated by combining genetic mapping with WES. This strategy markedly improves the genetic diagnosis of AMC, since pathogenic mutations were detected in known AMC or NMD genes in 19 families (61%). Importantly, this approach allowed identifying mutations in CNTNAP1 and ADCY6 in five families revealing novel axoglial human diseases. The fetal phenotype was quite similar and mainly characterized by a late onset during pregnancy, polyhydramnios (in four out of five families), distal joint contractures and very severe motor paralysis at birth leading to death within the first 3 months of life. A causative role of mutations in the CNTNAP1 gene encoding CASPR was established by the identification of distinct homozygous frameshift mutations in four unrelated families. In addition, dramatic reduction of motor nerve conduction velocities associated with severe abnormalities of the nodes of Ranvier and myelinated axons was observed. The node of Ranvier, the flanking paranodal junctions and the juxtaparanodes underlie saltatory conduction of action potentials along the myelinated axons, an essential process for neuronal function. The paranodal junctions consist of a complex containing the axonal proteins Caspr (12) and contactin (13) and the glial isoform of neurofascin (14) . Mice that lack Caspr exhibit severe motor paresis and most of the mutant mice die at weaning (P21, 9). In these mice, normal paranodal junctions fail to form leading to disruption of the paranodal loops. Our data show similar defects of myelinated axons, indicating a critical role for CASPR in the delineation of specific axonal domains and the axon -glia interactions required for normal saltatory conduction in both mouse and human. A homozygous missense mutation in ADCY6 has been found in a consanguineous family. Ultrastructural morphology of patient nerve sample revealed the presence of Schwann cells but the lack of myelin in the PNS. Although mutation of this gene has been found in a single family, knock down of the orthologous genes in zebrafish provided evidence for major myelin defects in the PNS, data similar to those found in patients. These results strongly support an essential and so far unknown role of ADCY6 in this process. ADCY6 encodes a protein that belongs to adenylate cyclase family responsible for the synthesis of cAMP (15) . During development, promyelinating Schwann cells associate with one segment of an axon and differentiate into myelinating Schwann cells to form the myelin sheath. Elevation of cAMP can mimic axonal contact in vitro and is thought to upregulate myelinating signals (16-18) . The G proteincoupled receptor Gpr126 has been recently shown to be required in Schwann cells for myelination (19) . Elevation of cAMP in gpr126 zebrafish mutants could restore myelination, suggesting that Gpr126 drives the differentiation of promyelinating Schwann cells by elevating cAMP levels (19) . Our data suggest that ADCY6 is involved in the same Gpr126-cAMP pathway for myelination of Schwann cells.
Hence, our study extends our knowledge of the pathogenic mechanisms in AMC and indicates that Caspr and Adcy6 are essential for correct differentiation of peripheral myelinated axons in human. These genes may be regarded as strong candidates in undiagnosed peripheral neuropathies.
In spite of some pitfalls, most likely due to the lack of coverage of mutations by WES, parallel next-generation sequencing (NGS) targeting previously known AMC genes, and the identification of two novel genes in this study should now lead to a molecular diagnosis in .75% of AMC cases, since our study concentrated on undiagnosed AMC only, without previous integration of muscle or nerve morphological studies. Such targeted NGS approach should avoid the identification of clinically relevant mutations unrelated to AMC. This will be particularly useful for diagnosis purpose and appropriate management.
MATERIALS AND METHODS
Patients
All cases were evaluated by obstetricians, fetal pathologists, clinical geneticists, neonatologists or neuropediatricians. The main clinical features of the affected individuals are summarized in Table 1 . The gestational age of AMC diagnosis was based on ultrasound examination. Any other defective organ was regarded as exclusion criteria. The parents of all patients provided written informed consents for genetic analysis of their children or fetuses and themselves in accordance with the ethical standards of our institutional review boards.
Methods
Genome-wide linkage analysis Genomic DNA was isolated from blood or frozen tissue with the use of a QiaAmp DNA midi or mini kit, respectively (Qiagen). Whole genome SNP scanning was carried out according to the Affymetrix 250 K GeneChip Mapping Assay manual. Multipoint linkage analysis and homozygosity mapping of SNP data were performed using the Alohomora (20) and Merlin software (21) with the following parameters: autosomal recessive or dominant inheritance, 100% penetrance and disease gene frequency in the population of 1:1000.
WES WES was performed using the DNA sample of one affected individual per family. The Illumina TruSeq DNA Sample Prep kit v1 and the NimbleGen SeqCap EZ Human Exome Library v2.0 (targeting 44 Mb, from A631 to A648 DNA samples) or v3.0 (targeting 64 Mb, from A649 to K199 DNA samples) were used for library preparation and exome enrichment, respectively, as previously described (22) . Sequencing was performed on a Genome Analyzer IIx instrument using paired-end 75 bp reads and following the Illumina's protocol. The median coverage of the WES was 33-138 (average 77).
Reads were aligned to the human reference genome sequence (UCSC hg19, NCBI build 37.3) via the BWA program (23) . Variants were selected using the SAMtools (24), then annotated using Annovar software (25) . Reads with a coverage of at least 2× were filtered against dbSNPv131 database. Variants with a MAF ,0.0015 and located in coding regions, intron -exon junctions or short coding insertions or deletions were selected. Then variants mapping to the candidate regions as determined by Real-time PCR amplification of genomic DNA Real-time PCR amplification was conducted using genomic DNA on a 7300 real-time PCR system (Applied Biosystems) using a Power SYBR Green PCR master mix (Applied Biosystems). Albumin gene was used as an internal control. Genomic deletion was defined when the ratio of tested DNA to control DNA was ,0.5. Real-time PCR amplification of each sample was performed in duplicate using primers within selected exons (Supplementary Material, Table S3 ).
Reverse transcription-PCR amplification Total RNAs were extracted by a TRI Reagent LS method (Sigma). One microgram RNA was used to synthesize Complementary DNA (cDNA) by using random primers following the manufacturer's manual (SuperScript III reverse Transcriptase, Invitrogen) in a final volume of 20 ml. PCR amplification was carried out using 1.5 mM MgCl 2 , 0.6 U DNA polymerase (Invitrogen), 0.2 mM each primer and 1 ml cDNA. After an initial cycle of denaturation at 948C for 5 min., 30 cycles were performed consisting in denaturation at 948C for 30 s., annealing at 608C for 1 min. and extension at 728C for 1 min., followed by a final extension for 7 min. at 728C, in a ABI9700 Thermal Cycler. RT-PCR products were separated by agarose gel electrophoresis and labelled with ethidium bromide. To determine the effect of mutations closed to intron -exon junctions, PCR amplification analysis from single-strand cDNA was performed using primers flanking exons (Supplementary Material, Table S3 ). As internal control for PCR amplification, b-Actin cDNA was coamplified (Supplementary Material, Table S3 ). Sanger sequencing was performed from the RT-PCR products.
Sanger sequencing PCR primer pairs were designed from genomic DNA to amplify and sequence each variant (Supplementary Material, Table S3 ). PCR amplification was carried out using 1.5 mM MgCl 2 , 0.6 U DNA polymerase, 0.25 mM each primer and 50 ng DNA. After an initial cycle of denaturation at 948C for 5 min, 30 cycles were performed consisting of denaturation at 958C for 30 s., annealing at 608C (+38C) for 1 min and extension at 728C for 1 min. and final extension 7 min. at 728C, on an ABI9700 Thermal Cycler. PCR products were then purified on P100 columns (Bio-Gel P-2 Gel fine, Biorad) sequenced using the forward or reverse primers and the Big Dye Terminator V3.1 Cycle sequencing kit (Applied Biosystems). The sequencing reaction products were purified on G50 columns (Sephadex G-50 Superfine, GE Healthcare), and then migrated on an automated fluorescent DNA sequencer (ABI Prism 3100 Genetic analyzer, Applied Biosystems). The obtained DNA sequences were compared with published sequences (BLAST, NCBI). Variants fulfilling prioritization criteria were validated by Sanger sequencing. Sanger sequencing was also performed to establish the genotype of each family member, and to analyze the segregation of the variants within each family. A cohort of 95 ethnically matched controls was analyzed for the selected variants when they were not known to be pathogenic so far.
Morphology of the neuromuscular system
Muscle and nerve biopsy samples were processed as previously described (26) . Nerve immunohistochemistry was carried out using a phosphorylated neurofilament monoclonal antibody (1:200), myelin basic protein (MBP, 1:200) and S100 protein polyclonal antibodies (1:2500, Dakopatts). Muscle and nerve ultrastructural studies were carried out according to the standardized protocols. Briefly, tissue samples were fixed in a 2% glutaraldehyde fixative solution, post-fixed with osmium tetroxide and embedded in resin epoxy. Semi-thin sections were stained with toluidine blue. Ultra-thin sections were contrasted with uranyl acetate and lead citrate, and examined under a PHILIPS CM10 transmission electron microscope.
Knockdown of ADCY6 in zebrafish Embryos were cared for according to the standard protocols (27) . Foxd3::GFP transgenic line was used here (11) . Antisense morpholino oligonucleotides (adcy6 MOs) were purchased from Gene Tools LLC and designed against the two corresponding orthologous zebrafish genes: adcy6a and adcy6b. The adcy6a MO was designed to target the 5 ′ UTR of adcy6a mRNA (XM_001922714, Supplementary Material, Table S3 ). The corresponding control 'mismatch' morpholino (Supplementary Material, Table S3 ) had five nucleotides altered along its sequence. The same applies to adcy6b MO targeting adcy6b mRNA (XM_002666490, Supplementary Material, Table S3 ). 0.3 mM of each of the two morpholinos, respectively, designed against the two genes were mixed (either a mix of the 5 ′ UTR MOs or the controls ones; final concentration: 0.6 mM). Morpholino (1 nl) was injected into one to four cell-stage embryos as previously described (28) .
In situ hybridization. Embryos were fixed in 4% paraformaldehyde and stained as whole mounts following standard in situ protocols and using mbp probe.
Immunohistochemistry. For immunostaining, embryos were fixed in 4% paraformaldehyde and stained as whole mounts. An anti-acetylated tubulin antibody (Sigma) was used at a 1:1000 dilution. Primary antibodies were detected with appropriate secondary antibodies conjugated to Alexa 568 (Molecular probes) at a 1:200 dilution.
Confocal image analysis. Image acquisition was performed using a Zeiss confocal microscope and Zeiss LSM imaging software. Image analysis was performed offline using ImageJ and Adobe photoshop CS6.
